Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Programmed cell death ligand 1 in correlation with BRAFV600E mutation, molecular characteristics and biological behavior in ameloblastoma.

Frontiers in immunology - 1 Jan 2026

Pan Aijing, Xie Zhipeng, Zhan Jianhui, Zhao Yifeng, Du Yue, Zhang Kai

Abstract excerpt

Objective: To investigate the expression of Programmed cell death ligand 1 (PD-L1) in Ameloblastoma (AM) and its correlation with BRAFV600E mutation as well as the expression of Cytotoxic CD8+ T cells (CD8+ T) and Forkhead box protein 3 (FoxP3) in the immune microenvironment. And to preliminarily explore the potential association of PD-L1 with the biological behavior and Disease-free survival (DFS) of patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ameloblastoma
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD8-Positive T-Lymphocytes

Share to Forkhead Transcription Factors

Share to Immunohistochemistry

Share to Jaw Neoplasms

Share to Proto-Oncogene Proteins B-raf

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 42382766
DOI: 10.3389/fimmu.2026.1762600
PMCID: PMC13314622

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Programmed cell death ligand 1 in correlation with BRAFV600E mutation, molecular characteristics and biological behavior in ameloblastoma.PMID 42382766Read ↗

Programmed death-ligand 1 regulates ameloblastoma growth and recurrenceSemantic proximity Read ↗

Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytesSemantic proximity Read ↗

BRAF p.V600E Mutational Status Does Not Correlate with Biological Behavior in Conventional Ameloblastomas: A Disease-Free Survival Analysis.Semantic proximity Read ↗

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomasSemantic proximity Read ↗

Molecular biology exploration and targeted therapy strategy of Ameloblastoma.Semantic proximity Read ↗

BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.Semantic proximity Read ↗

Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres.Semantic proximity Read ↗

Effectiveness of molecular-targeted chemotherapy in ameloblastomas: A systematic review.Semantic proximity Read ↗

Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma.Semantic proximity Read ↗

Molecular pathogenesis of ameloblastoma.Semantic proximity Read ↗

Prevalence and clinicopathological correlation of BRAF V600E mutations in ameloblastoma: A PCR study from a tertiary centre in South India.Semantic proximity Read ↗

Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.